Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial. - Qiao YL; Wu T; Li RC; Hu YM; Wei LH; Li CG; Chen W; Huang SJ; Zhao FH; Li MQ; Pan QJ; Zhang X; et al. (Journal of the National Cancer Institute, 2020)